XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/23/2026
Back to search
Official data from USPTO
PROMISE ADVANCED PROTEOMICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079203268Class
1, 5, 41, 42, 44
Filing
79203268
Registration
5494434
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/23/2026
Trademark type
Combined
Nice classes
1, 5, 41, 42, 44
Filing date
10/18/2016
Registration date
06/19/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
GRENOBLE CEDEX 9, FR
Examiner
TWOHIG, SHANNON MARIE
Law office
N30
Current location
TMO LAW OFFICE 121
Mark description
The mark consists of the stylised word "PROMISE" in black, with the letter "I" consisting of four circles in red, green, purple and blue. Below the word "PROMISE" is the stylised wording "ADVANCED PROTEOMICS" in red.
Holders and representatives
Holders
P. P. (pessoa física)
PROMISE ADVANCED PROTEOMICS, SARL
Representatives
Brooks R. Bruneau FisherBroyles LLP
Technical classification
Nice Classes
Class 1Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological products for use in industryscience other than medicalas well as in agriculturehorticultureforestry and the agri-food industrynamely isotopesmonoclonal antibodiesisotopic proteins and polypeptides; proteins as a raw material for scientific and medical research and for use in the manufacture diagnosis kits
Class 5
Sanitary products for therapeutic usenamely diagnosis kits and drug testing kits; pharmaceuticalveterinarychemicalbiochemical or biological preparations for medical or veterinary use; proteins for medical or veterinary usenamely monoclonal antibodiesisotopic proteinsisotopes and polypeptides for use in diagnosis kits for disease testing
Class 41
Editing of booksmanualsmagazinesCD-ROMscomputer data for use on computer or telephone networks; organization of exhibitions or events for cultural or educational purposes
Class 42
Scientific and industrial researchin particular relating to chemistrybiochemistrybiotechnology and biology; computer programmingdesignrentalupdating and maintenance of software; technical adviceconsultancy and informationparticularly relating to chemistrybiochemistrybiotechnology and biologytechnical support and advice for the draftingdevelopment and implementation of methodsprotocols and processes for protein production and analysis; testing of chemicalbiochemicalbiotechnological and biological materials and substances for research and development and diagnosis purposes
Class 44
Medical services and particularly research and development of therapeutic strategies; veterinary services and medical analysis services related to the treatment of individualsnamely providing x-ray examinationsblood testing services and diagnosis of diseases
Publications
History of USPTO decisions and trademark events.
39 publications found
XXCR
GENERIC MADRID TRANSACTION CREATED
07/23/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/29/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/29/2025
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
04/29/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/28/2025
ES71
TEAS SECTION 71 RECEIVED
12/17/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/25/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/24/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/13/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/14/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/12/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/26/2018
FIMP
FINAL DISPOSITION PROCESSED
09/26/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/19/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/19/2018
PUBO
PUBLISHED FOR OPPOSITION
04/03/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/30/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/14/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/14/2018
NPUB
NOTICE OF PUBLICATION
03/14/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2018
CNEA
EXAMINERS AMENDMENT MAILED
02/20/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/19/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/19/2018
CNRT
NON-FINAL ACTION MAILED
07/24/2017
CNRT
NON-FINAL ACTION WRITTEN
07/24/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2017
RFNT
REFUSAL PROCESSED BY IB
04/15/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/24/2017
RFRR
REFUSAL PROCESSED BY MPU
03/24/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/21/2017
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2017
CNRT
NON-FINAL ACTION WRITTEN
03/20/2017
DOCK
ASSIGNED TO EXAMINER
03/17/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/16/2017
Continuous trademark protection
Get notified about every new filing that threatens PROMISE ADVANCED PROTEOMICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.